Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.786123
Title: Linking glucocorticoid action and hypoxia : a novel mechanism driving an adverse metabolic phenotype?
Author: Hazlehurst, Jonathan
ISNI:       0000 0004 7971 5905
Awarding Body: University of Oxford
Current Institution: University of Oxford
Date of Award: 2018
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
Obstructive sleep apnoea (OSA) is characterised by repeated cycles of reduced and complete obstruction of air flow occurring in sleep. This can result in decreased oxygen levels (hypoxia). OSA and states of glucocorticoid excess are both associated with metabolic diseases including fatty liver disease. Whether increased glucocorticoids are a feature of OSA and may contribute to the increased metabolic risk seen in OSA is unknown. In vitro, patient and healthy volunteer studies were employed to assess adipose response to hypoxia. Further metabolic effects of acute and chronic intermittent hypoxia (AIH and CIH) were examined in healthy volunteers and rodents respectively. The AIH study incorporated glucocorticoid receptor (GR) blockade. The patient study also examined the effect of OSA on glucocorticoid availability. Adipocytes were sensitive to extreme hypoxia in vitro although this was not seen in adipose biopsies from patients with OSA or in assessment of adipose function in AIH. AIH in man and CIH in rodents resulted in increased de novo lipogenesis (DNL). Sham CPAP was associated with increased urinary glucocorticoids. GR blockade limited adipose tissue fatty acid mobilisation but did not affect the metabolic impact of AIH on DNL. Intermittent hypoxia drives DNL. OSA is associated with increased glucocorticoids. Despite this GR blockade was not protective against the effects of intermittent hypoxia in this model and is unlikely to be a useful therapeutic target therefore in patients with OSA.
Supervisor: Hodson, Leanne ; Tomlinson, Jeremy Sponsor: Wellcome Trust
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.786123  DOI: Not available
Share: